This review highlights that many indications for anti-platelet therapy in pediatric cardiology are empirical and lack controlled pediatric studies.
Pediatric patients with a variety of congenital and acquired cardiac conditions receive antithrombotic therapy. Many of the indications are empirical, and have either not been proven in controlled studies or are extrapolated from adult studies. This article reviews the current available literature regarding the use of anti-platelet drugs in the pediatric cardiac population.
Vaidyanathan et al. (Tue,) studied this question.